IL138220A0 - 3',3',-n-bis substituted macrolide lhrh antagonists - Google Patents

3',3',-n-bis substituted macrolide lhrh antagonists

Info

Publication number
IL138220A0
IL138220A0 IL13822099A IL13822099A IL138220A0 IL 138220 A0 IL138220 A0 IL 138220A0 IL 13822099 A IL13822099 A IL 13822099A IL 13822099 A IL13822099 A IL 13822099A IL 138220 A0 IL138220 A0 IL 138220A0
Authority
IL
Israel
Prior art keywords
lhrh antagonists
bis substituted
substituted macrolide
macrolide lhrh
bis
Prior art date
Application number
IL13822099A
Other languages
English (en)
Original Assignee
Abbott Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abbott Lab filed Critical Abbott Lab
Publication of IL138220A0 publication Critical patent/IL138220A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H1/00—Processes for the preparation of sugar derivatives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Genetics & Genomics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biotechnology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Diabetes (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
IL13822099A 1998-03-27 1999-03-22 3',3',-n-bis substituted macrolide lhrh antagonists IL138220A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/049,458 US5972898A (en) 1998-03-27 1998-03-27 3',3-N-bis-substituted macrolide LHRH antagonists
PCT/US1999/006250 WO1999050276A1 (en) 1998-03-27 1999-03-22 3',3'-n-bis-substituted macrolide lhrh antagonists

Publications (1)

Publication Number Publication Date
IL138220A0 true IL138220A0 (en) 2001-10-31

Family

ID=21959914

Family Applications (1)

Application Number Title Priority Date Filing Date
IL13822099A IL138220A0 (en) 1998-03-27 1999-03-22 3',3',-n-bis substituted macrolide lhrh antagonists

Country Status (18)

Country Link
US (1) US5972898A (sk)
EP (1) EP1066307A1 (sk)
JP (1) JP2002509938A (sk)
KR (1) KR20010034699A (sk)
CN (1) CN1303389A (sk)
AU (1) AU3197599A (sk)
BG (1) BG104827A (sk)
BR (1) BR9909121A (sk)
CA (1) CA2325519A1 (sk)
HU (1) HUP0102522A3 (sk)
IL (1) IL138220A0 (sk)
NO (1) NO20004807L (sk)
NZ (1) NZ506622A (sk)
PL (1) PL343152A1 (sk)
SK (1) SK13982000A3 (sk)
TR (1) TR200002766T2 (sk)
WO (1) WO1999050276A1 (sk)
ZA (1) ZA200005030B (sk)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6387885B1 (en) * 1998-08-26 2002-05-14 Abbott Laboratories 3′,3′-N-bis-desmethyl-3′-N-cycloalkyl erythromycin derivatives as LHRH antagonists
DE60138876D1 (de) * 2000-03-28 2009-07-16 Sandoz Ag Geschmackmaskierte granulierte teilchen
EP1146051A3 (en) * 2000-04-10 2001-10-31 Pfizer Products Inc. Erythromycin A derivatives
KR100876538B1 (ko) 2000-08-17 2008-12-31 아에테르나 젠타리스 게엠베하 Ｌｈｒｈ 길항제의 염의 제조방법
JP5314835B2 (ja) 2000-11-15 2013-10-16 昌雄 菅又 子宮内膜症の予防又は治療薬
AU2003202115A1 (en) 2002-02-12 2003-09-04 Pfizer Inc. Non-peptide compounds affecting the action of gonadotropin-releasing hormone (gnrh)
JP2005538064A (ja) 2002-06-13 2005-12-15 ファイザー・インク 非ペプチドＧｎＲＨ剤、医薬組成物、およびそれらの使用方法
WO2007060518A2 (en) * 2005-11-23 2007-05-31 Ranbaxy Laboratories Limited Ketolide derivatives as antibacterial agents
AU2010256360A1 (en) 2009-06-05 2012-01-12 Astrazeneca Ab Aminopyrrolidinone derivatives and uses thereof
AR085286A1 (es) * 2011-02-21 2013-09-18 Taisho Pharmaceutical Co Ltd Derivado de macrolido sustituido en la posicion c-4

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6187625A (ja) * 1984-10-05 1986-05-06 Satoshi Omura 消化管収縮運動促進剤
EP0215355B1 (en) * 1985-08-31 1994-04-06 Kitasato Kenkyusho Erythromycin derivative and process for preparing the same
US4742049A (en) * 1986-06-04 1988-05-03 Abbott Laboratories Semisynthetic erythromycin antibiotics
US4920102A (en) * 1988-04-18 1990-04-24 Eli Lilly And Company Method for treating gastrointestinal disorders
IL114589A (en) * 1990-11-21 1999-12-22 Roussel Uclaf Intermediates for the preparation of the history of erythromycin
DE69127457T2 (de) * 1990-11-28 1998-01-22 Taisho Pharmaceutical Co., Ltd., Tokio/Tokyo 6-0-methylerythromycin a-derivat
FR2727969B1 (fr) * 1994-12-09 1997-01-17 Roussel Uclaf Nouveaux derives de l'erythromycine, leur procede de preparation et leur application comme medicaments
PL327146A1 (en) * 1995-12-14 1998-11-23 Merck & Co Inc Antagonists of the gonadotrophin liberating hormone
CZ351898A3 (cs) * 1996-05-07 1999-04-14 Abbott Laboratories 6-0-substituované erythromycinové sloučeniny a způsob jejich přípravy

Also Published As

Publication number Publication date
SK13982000A3 (sk) 2001-04-09
PL343152A1 (en) 2001-07-30
TR200002766T2 (tr) 2001-01-22
KR20010034699A (ko) 2001-04-25
WO1999050276A1 (en) 1999-10-07
NO20004807D0 (no) 2000-09-26
BG104827A (en) 2001-07-31
CA2325519A1 (en) 1999-10-07
US5972898A (en) 1999-10-26
ZA200005030B (en) 2001-08-10
BR9909121A (pt) 2000-12-19
CN1303389A (zh) 2001-07-11
NO20004807L (no) 2000-11-24
AU3197599A (en) 1999-10-18
HUP0102522A3 (en) 2003-08-28
NZ506622A (en) 2003-03-28
EP1066307A1 (en) 2001-01-10
HUP0102522A2 (hu) 2001-10-28
JP2002509938A (ja) 2002-04-02

Similar Documents

Publication Publication Date Title
DE69941083D1 (en) 12,13-cyclopropan-epothilonderivate
GC0000108A (en) 4-Amino substituted-2-substituted-1,2,3,4-tetrahy droquinolines.
HK1035501A1 (en) Rapidly disintegrable solid preparation.
PL337057A1 (en) 2-substituted 4,5-diarylimidazoles
MXPA02001088A (es) 2-pirazolin-5-onas..
ZA200003927B (en) 1,2,4,5-tetrahydro-benzo[d]jazepines.
HK1030387A1 (en) Shank fitting structure.
ZA997174B (en) Antiparasitic formulations.
DE69818977D1 (en) 3'-n-oxid,3'-n-dimethylamin,9-oxime erythromycin a derivate
ZA982225B (en) LHRH antagonists.
ZA987688B (en) 6,9-bridged erythromycin derivatives
IL134996A0 (en) 6,11-bridged erythromycin derivatives
IL138220A0 (en) 3',3',-n-bis substituted macrolide lhrh antagonists
EP1087900A4 (en) PERFECTED PALLETIZER
GB9810998D0 (en) Antitumour 1,5-diazaanthraquinones
HUP0204169A3 (en) Substituted 1,2,3,4,5,6-hexahydro-2,6-methano-3-benzazocines an
IL146124A0 (en) 1,5-benzodiazepine derivatives
SI1066304T1 (en) Macrolide lhrh antagonists
ZA981529B (en) Substituted 2,4-diaminopyrimidine
GB9815537D0 (en) 2,6-Quinolines
EG23327A (en) Metraplant "iucd".
ZA99626B (en) "A-Lock".
ZA200003881B (en) "Detonator block".
GB2342388B (en) Barrier
TW334681U (en) Improved catchers structure